Search research articles
Contact Us
Filters
Showing results (121-130 of 222) with videos related to
Page
of 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
Eric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Metabolites
|
March 3, 2021
Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models
Jinny Sun, Robert A Bok, Justin DeLos Santos, et al.
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Prostate Cancer
|
October 10, 2022
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
Rahul Aggarwal, Joshi J Alumkal, Russell Z Szmulewitz, et al.
American Journal of Preventive Cardiology
|
April 20, 2026
Cardiovascular outcomes with icosapent ethyl by burden of standard modifiable cardiovascular risk factors in REDUCE-IT
Rahul Aggarwal, Deepak L Bhatt, Michael Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies
Rahul Aggarwal, Scott Thomas, Nela Pawlowska, et al.
Nature Cardiovascular Research
|
June 13, 2025
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction
Rahul Aggarwal, Deepak L Bhatt, Adrian F Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Clinical Genitourinary Cancer
|
March 22, 2023
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Emerson A Lim, Michael T Schweizer, Kim N Chi, et al.
Clinical Genitourinary Cancer
|
October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
Mina Lee, Haemin Hong, Won Kim, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 222) with videos related to
Sort By:
Page
of 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
Eric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Metabolites
|
March 3, 2021
Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models
Jinny Sun, Robert A Bok, Justin DeLos Santos, et al.
Cancer
|
August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Prostate Cancer
|
October 10, 2022
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
Rahul Aggarwal, Joshi J Alumkal, Russell Z Szmulewitz, et al.
American Journal of Preventive Cardiology
|
April 20, 2026
Cardiovascular outcomes with icosapent ethyl by burden of standard modifiable cardiovascular risk factors in REDUCE-IT
Rahul Aggarwal, Deepak L Bhatt, Michael Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies
Rahul Aggarwal, Scott Thomas, Nela Pawlowska, et al.
Nature Cardiovascular Research
|
June 13, 2025
Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction
Rahul Aggarwal, Deepak L Bhatt, Adrian F Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
Ivan de Kouchkovsky, Arpit Rao, Benedito A Carneiro, et al.
Clinical Genitourinary Cancer
|
March 22, 2023
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Emerson A Lim, Michael T Schweizer, Kim N Chi, et al.
Clinical Genitourinary Cancer
|
October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
Mina Lee, Haemin Hong, Won Kim, et al.
Page
of 23